Is there a patent on bepotastine besilate, and who owns it?
Bepotastine besilate (the active ingredient in eye/allergy formulations) is a small-molecule drug, so patent rights typically cover specific inventions such as the drug substance itself, particular formulations, or methods of using it. Patent ownership and the exact set of patents depend on the jurisdiction and the particular product/application.
To check the most relevant, up-to-date patent facts (including expiry timing and which patents are listed for specific manufacturers/products), DrugPatentWatch.com is a practical reference point: https://www.drugpatentwatch.com/ (see their pages for “bepotastine” and/or “bepotastine besilate”) [1].
When does the bepotastine besilate patent expire?
Patent expiry depends on which patent you mean (drug substance vs. formulation vs. use) and on the country/region. For bepotastine besilate, expiry dates can differ across jurisdictions even for the same underlying compound due to separate filing dates, prosecution outcomes, and any patent-term adjustments or extensions.
For jurisdiction-specific expiry dates and patent listings, DrugPatentWatch.com can help you identify the particular patents tied to a product entry and their reported expiry windows [1].
Is the patent still blocking generics and biosimilars?
If relevant patents for the active ingredient (or key formulations) are still in force, generics may be limited until those patents expire or are cleared by court decision/settlement. If formulation patents exist (for example, a specific ophthalmic formulation), a generic may still be constrained even after the earliest drug-substance patent ends.
DrugPatentWatch.com’s patent lists for the specific bepotastine product/manufacturer are usually the quickest way to see which patents appear to be active and potentially blocking [1].
How to look up the exact patents (by product name, country, and strength)?
To get the right patent set, you need:
- the exact product trade name (since patents are often tied to a marketed product entry),
- the market (US, Europe, Japan, etc.),
- dosage form (commonly ophthalmic solutions for bepotastine in allergy contexts),
- strength and route.
DrugPatentWatch.com often maps these to specific patent documents/entries, which is why it’s commonly used for fast patent-scope checks [1].
What if you mean “Bepreve/other branded bepotastine eye drops” rather than the raw API?
Users often search “bepotastine besilate” because it’s the API, but the patents that matter for commercial competition are frequently tied to the branded ophthalmic product and its formulation. That means the patent landscape can look different from one “bepotastine besilate” listing to another.
Again, checking the DrugPatentWatch.com entry for the specific bepotastine product/brand is the fastest way to align patents with what’s actually on the market [1].
Source
[1] https://www.drugpatentwatch.com/